Celltrion
068270.KS
#724
Rank
โ‚น2.329 T
Marketcap
โ‚น11,367
Share price
0.05%
Change (1 day)
-5.51%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): โ‚น245.26

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น254.97. In 2022 the company made an earnings per share (EPS) of โ‚น248.21 a decrease over its 2021 EPS that were of โ‚น294.93.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น245.26-1.19%
2022โ‚น248.21-15.84%
2021โ‚น294.9312.77%
2020โ‚น261.5370.79%
2019โ‚น153.1315.63%
2018โ‚น132.43-33.13%
2017โ‚น198.05141.17%
2016โ‚น82.128.28%
2015โ‚น75.8411.28%
2014โ‚น68.1616.37%
2013โ‚น58.57-67.42%
2012โ‚น179.7984.22%
2011โ‚น97.6062.13%
2010โ‚น60.2080.61%
2009โ‚น33.33-559.63%
2008-โ‚น7.25-123.16%
2007โ‚น31.31